scholarly journals Maternal C677T variant in MTHFR gene as a risk factor of neural tube defect: A case study

Author(s):  
Wenchao Sun ◽  
Xiaohong Song ◽  
Lin Zhang ◽  
Xiaoyang Fei
2008 ◽  
Vol 49 (2) ◽  
pp. 106-108 ◽  
Author(s):  
W. Dickey ◽  
F. Stewart ◽  
J. Nelson ◽  
G. McBreen ◽  
S. A. McMillan ◽  
...  

2005 ◽  
Vol 8 (8) ◽  
pp. 1235-1241 ◽  
Author(s):  
Mark Lawrence

AbstractObjectiveTo identify challenges in translating scientific evidence of a nutrient and health relationship into mandatory food fortification policy.DesignA case study approach was used in which available evidence associated with the folate–neural tube defect relationship was reviewed against the Australia New Zealand Food Regulation Ministerial Council's Policy Guideline for mandatory food fortification.ResultsThree particular challenges were identified. The first is knowing when and how to act in the face of scientific uncertainty. The second is knowing how to address the special needs of at-risk individuals without compromising the health and safety of the population as a whole. The third is to ensure that a policy is sufficiently monitored and evaluated.ConclusionsDespite the availability of compelling evidence of a relationship between a particular nutrient and a health outcome, a definitive policy response may not be apparent. Judgement and interpretation inevitably play significant roles in influencing whether and how authorities translate scientific evidence into mandatory food fortification policy. In relation to the case study, it would be prudent to undertake a risk–benefit analysis of policy alternatives and to implement nutrition education activities to promote folic acid supplement use among the target group. Should mandatory folate fortification be implemented, comprehensive monitoring and evaluation of this policy will be essential to know that it is implemented as planned and does more good than harm. In relation to mandatory food fortification policy-making around the world, ongoing national nutrition surveys are required to complement national policy guidelines.


The Lancet ◽  
1998 ◽  
Vol 351 (9115) ◽  
pp. 1554-1555 ◽  
Author(s):  
LR Weitkamp ◽  
DC Tackels ◽  
AGW Hunter ◽  
LB Holmes ◽  
CE Schwartz

2009 ◽  
Vol 21 (7) ◽  
pp. 805-808 ◽  
Author(s):  
Rodrigo Coutinho de Almeida ◽  
Benicio Oton Lima ◽  
Luiz Claudio Castro ◽  
Lenora Gandolfi ◽  
Riccardo Pratesi

2019 ◽  
Author(s):  
Shafira Nur Hanifa

Folic acid is an essential nutrient that is needed for DNA replication which is directed to the cell proliferation. Folic acid is activated by MTHFR gene through enzymatic reaction. It could be found in nature food and also in a supplement. Demands for folate increase during pregnancy because it is also required for growth and development of the fetus. Folate deficiency has been associated with abnormalities in both mothers (anemia, peripheral neuropathy) and fetuses (congenital abnormalities with high risk of morbidity). Folic acid deficiency is related to neural tube defect that directed to spina bifida occulta. The pregnancy women need an extra folic acid for about 0,4 mg per day in a normal case and In high risk pregnancies (previously affected) this dose is recommended for 1–3 months prior to conception. This article reviews the knowledge of pregnancy women about the function of folic acid in preventing spina bifida occulta due to the amount of neural tube defect case is on the top three of the congenital abnormalities and the doctor’s role in compressing the risk of spina bifida occulta


2009 ◽  
Vol 39 (6) ◽  
pp. 20
Author(s):  
ELIZABETH MECHCATIE

Sign in / Sign up

Export Citation Format

Share Document